Myeloid Neoplasia: A Review of Clinical Features and Diagnostic Criteria - Part 3: The Acute Myeloid Leukemias

CME : 1.25
Start Date :  Jun 07, 2018End Date :  Jun 06, 2021

Organized by :   Opus Medicus, Inc.

Specialties :   Oncology, Hematology Blood and Marrow Transplant, Haematology

Fees Fee :   Starting From USD 30

Conference Summary

Myeloid Neoplasia: A Review of Clinical Features and Diagnostic Criteria - Part 3: The Acute Myeloid Leukemias is organized by Opus Medicus, Inc.

Release Date: Jun 07, 2018
Expiration Date: Jun 06, 2021

Accreditation:
This CME Conference has been approved for a maximum of 1.25 AMA PRA Category 1 Credit(s)™.

Course Description:
This course is part 3 of a 3 part series that covers the diagnostic criteria and clinicopathologic features of the acute myeloid leukemias.

Topics:
• Acute Myeloid Leukemia Diagnostic Criteria and Markers
• Caveats about AML Presentation
• Hypocellular AML
• AML with t (8:21)
• Acute promyelocytic leukemia (M3) with t(15;17)
• AML with various translocations
• Myelodysplastic features
• AMLs (formerly M0-M7)
• Acute basophilic leukemia
• Acute panmyelosis with myelofibrosis
• Myeloid Sarcoma
• Down syndrome related myeloid proliferations
• Blastic plasmacytoid dendritic cell neoplasm
• Acute leukemias of ambiguous lineage
• Acute Myeloid Leukemia Diagnostic Criteria and Markers

Conference Objectives are:
• To compare and contrast the general features of MDS, MPD, and AML
• To delineate the specific diagnostic criteria for all WHO-recognized AML subtypes, including clinical, histologic, immunophenotypic, and genetic features.

Additional details will be posted as soon as they are available.

Credit Info

  • CME : 1.25
Speaker (s)
1 Speaker(s)
Contact Us

Toll free Number

1(800) 826-2059

Email

support@eMedEvents.com

Chat Assistant

Live Chat
Recommended